from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1745c/idi

LFCtreatmentdescriptionclass of inhibitor

0.821

Amikacinug/mL Amikacintranslation

0.478

Cap5-10ug/mL Capreomycintranslation

1.038

Rox10-50 ug/mL Roxithromycintranslation

-1.531

SM2-5 ug/mL Streptomycintranslation

-0.326

Tet5-10 ug/mL Tetracyclinetranslation

0.696

Rif0.2-5ug/mL Rifampicintranscription

0.786

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.090

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.946

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.305

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.764

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.441

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.640

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.866

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.312

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.985

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.656

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.454

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.363

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.360

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.005

KCN5-20 ug/mL Potassium cyaniderespiration

-0.329

NaN30.2-2 mM Sodium aziderespiration

-0.766

Nigericin50 uM Nigericinrespiration

0.483

TRC10-150 ug/mL Triclosanrespiration

0.593

TRZ10-25 ug/mL Thioridazinerespiration

-0.920

Valinomycin0.5-10 uM Valinomycinrespiration

-0.420

ZnSO42 mM ZnSO4respiration

-0.374

menadione6-10 ug/mL Menadionerespiration

-0.209

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.272

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.264

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.244

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.026

NRP_1Non-replicating persistence stage 1dosRassociated

-0.619

Amp0.2mg/mL AmpicillincellWall

0.240

Cephalexin20-100 ug/mL CephalexincellWall

-0.259

Cerulenin0.32-5 ug/mL CerulenincellWall

1.421

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.775

EMB10-20 ug/mL EthambutolcellWall

0.098

Eta12-40 ug/mL EthionamidecellWall

-0.642

INH0.2-0.4 ug/mL IsoniazidcellWall

0.401

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.300

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.443

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.067

BZA0.12 mg/mL BenzamidearomaticAmides

-0.063

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.039

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.311

H2O24 mM hydrogen peroxideDNAdamaging

-0.272

Levo10 ug/mL LevofloxacinDNAdamaging

0.147

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.037

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.546

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.537

UVUV-irradiationDNAdamaging

0.341

ARP41-4 ug/mL Antitubercular compound ARP4?

0.505

Antimycin12.5-50 ug/mL Antimycin A?

-0.266

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.310

PA_110-50 ug/mL Antitubercular compound PA-1?

0.033

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.633

PA8240.2-2 ug/mL PA-824?

-0.760

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.002

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.025

Verapamil50 uM Verapamil?

-0.117

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.505

methoxatin10-20 ug/mL Methoxatin?